Quick-Med Technologies, Inc., awarded contract for burn treatment technology
Quick-Med's NIMBUS technology was chosen for the award under the Small Business Innovation Research program for the DoD Defense Health Program. The SBIR program was established by the U.S. Congress and supports scientific progress by offering competitive award contracts to the most innovative companies.
This contract will be a continuation of a blister treatment Quick-Med made and presented to the U.S. Army in 2011, where it received first place for Industrial Research and Development at the Annual Meeting of the Wound Healing Society. This new award will allow the organization to expand its research for military and civilian thermal burns.
"We are very pleased to have been competitively selected for this important advanced research program into dressings that can speed wound healing," Quick-Med President Bernd Liesenfeld said. "This award is a further validation of our NIMBUS antimicrobial technology platform and will enable us to continue our development a series of products that accelerate wound healing and help prevent microbial contamination."
Phase I of the project, valued at $150,000, is geared towards designing "a new innovative technology to intervene during the wound healing process, including inflammatory, proliferative and/or remodeling stages, to attenuate/control scar contracture and retain skin aesthetics and following deep tissue burn injuries." The work will begin immediately and is expected to be complete near the end of the calendar year; subsequent phases that may result are expected to be valued at close to $1 million when the technology is ready for commercial expansion.
Part of the research will be conducted at the University of Florida's Institute for Wound Research. Approximately 2.4 million thermal burns occur annually within the U.S. alone; the new technology seeks to reduce scarring and contracture in healing of severe burns.
"The NIMBUS super-absorbent polymer technology allows Quick-Med to develop a unique dressing that provides antimicrobial protection for the wound while also acting to minimize scar tissue formation, and inhibit matrix metalloproteinases to block contracture of tissues," Director of the Institute for Wound Research at the University of Florida Professor Greg Schultz said. "This unique combination therapy should speed healing and reduce contraction of severe burns in our wounded warriors. It would also have extensive application for civilians with large burns."